Co-stimulation with TNF receptor superfamily 4/25 antibodies enhances in-vivo expansion of CD4+CD25+Foxp3+ T cells (Tregs) in a mouse study for active DNA Aβ42 immunotherapy

Journal of Neuroimmunology

Volumn 278, Issue , 2015, Pages 90-99

  Lambracht Washington, Doris ^a   Rosenberg, Roger N ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Alzheimer disease; DNA A 42 immunization; Skin immunity; Th2 Treg differentiation; TNFRSF4 25 antibody co stimulation

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; DNA AMYLOID BETA PROTEIN 42 VACCINE; DNA VACCINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR HELIOS; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 25 ANTIBODY; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 4 ANTIBODY; UNCLASSIFIED DRUG; AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (1-42); ANTIBODY; CD134 ANTIGEN; CYTOKINE; DEATH RECEPTOR 3; DNA; DNA BINDING PROTEIN; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, MOUSE; GATA3 PROTEIN, MOUSE; PEPTIDE FRAGMENT; TNFRSF25 PROTEIN, MOUSE; TNFRSF4 PROTEIN, MOUSE; ZFPN1A2 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL EXPANSION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FEMALE; IMMUNOTHERAPY; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE COUNT; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SPLEEN CELL; T LYMPHOCYTE ACTIVATION; TH2 CELL; ALZHEIMER DISEASE; ANIMAL; BAGG ALBINO MOUSE; BLOOD; CELL CULTURE; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; SPLEEN; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; ANTIBODIES; CELLS, CULTURED; CYTOKINES; DNA; DNA-BINDING PROTEINS; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GATA3 TRANSCRIPTION FACTOR; HUMANS; IMMUNOTHERAPY; MALE; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; PEPTIDE FRAGMENTS; RECEPTORS, OX40; RECEPTORS, TUMOR NECROSIS FACTOR, MEMBER 25; SPLEEN; T-LYMPHOCYTES, REGULATORY; TRANSCRIPTION FACTORS;

EID: 84920911203     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2014.12.007     Document Type: Article

References (33)

1. Akimova T., Beier U.H., Wang L., Levine M.H., Hancock W.W. Helios expression is a marker of T cell activation and proliferation. PLoS One 2011, 6(8):e24226.
2. Booth N.J., McQuaid A.J., Sobande T., Kissane S., Agius E., Jackson S.E., Salmon M., Falciani F., Yong K., Rustin M.H., Akbar A.N., Vukmanovic-Stejic M. Different proliferative potential and migratory characteristics of human CD4+ regulatory T cells that express either CD45RA or CD45RO. J. Immunol. 2010, 184:4317-4326.
3. Bouaziz J.D., Yanaba K., Tedder T.F. Regulatory B cells as inhibitors of immune responses and inflammation. Immunol. Rev. 2008, 224:201-214.
4. Carrillo M.C., Brashear H.R., Logovinsky V., Ryan J.M., Feldman H.H., Siemers E.R., Abushakra S., Hartley D.M., Petersen R.C., Khachaturian A.S., Sperling R.A. Can we prevent Alzheimer's disease? Secondary "prevention" trials in Alzheimer's disease. Alzheimers Dement. 2013, 9:123-131.
5. Chapoval S., Dasgupta P., Dorsey N.J., Keegan A.D. Regulation of the T helper cell type 2 (Th2)/T regulatory cell (Treg) balance by IL-4 and STAT6. J. Leukoc. Biol. 2010, 87:1011-1018.
6. Clark R.A., Kupper T.S. IL-15 and dermal fibroblasts induce proliferation of natural regulatory T cells isolated from human skin. Blood 2007, 109:194-202.
7. Cribbs D.H., Ghochikyan A., Vasilevko V., Tran M., Petrushina I., Sadzikava N., Babikyan D., Kesslak P., Kieber-Emmons T., Cotman C.W., Agadjanyan M.G. Adjuvant-dependent modulation of Th1 and Th2 responses to immunization with beta-amyloid. Int. Immunol. 2003, 15:505-514.
8. Davidson T.S., DiPaolo R.J., Andersson J., Shevach E.M. Cutting Edge: IL-2 is essential for TGF-beta-mediated induction of Foxp3+ T regulatory cells. J. Immunol. 2007, 178:4022-4026.
9. Dudda J.C., Perdue N., Bachtanian E., Campbell D.J. Foxp3+ regulatory T cells maintain immune homeostasis in the skin. J. Exp. Med. 2008, 205:1559-1565.
10. Fox N.C., Black R.S., Gilman S., Rossor M.N., Griffith S.G., Jenkins L., Koller M. Effects of Abeta immunization (AN1792) on MRI measures of cerebral volume in Alzheimer disease. Neurology 2005, 64:1563-1572.
11. Fujio K., Okamura T., Yamamoto K. The Family of IL-10-secreting CD4+ T cells. Adv. Immunol. 2010, 105:99-130.
12. Gilman S., Koller M., Black R.S., Jenkins L., Griffith S.G., Fox N.C., Eisner L., Kirby L., Rovira M.B., Forette F., Orgogozo J.M. Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial. Neurology 2005, 64:1553-1562.
13. Gratz I.K., Rosenblum M.D., Maurano M.M., Paw J.S., Truong H.A., Marshak-Rothstein A., Abbas A.K. Cutting edge: self-antigen controls the balance between effector and regulatory T cells in peripheral tissues. J. Immunol. 2014, 192:1351-1355.
14. Khan S.Q., Tsai M.S., Schreiber T.H., Wolf D., Deyev V.V., Podack E.R. Cloning, expression, and functional characterization of TL1A-Ig. J. Immunol. 2013, 190:1540-1550.
15. Lambracht-Washington D., Rosenberg R.N. Advances in the development of vaccines for Alzheimer's disease. Discov. Med. 2013, 15:319-326.
16. Lambracht-Washington D., Qu B.X., Fu M., Eagar T.N., Stüve O., Rosenberg R.N. DNA beta-amyloid (1-42) trimer immunization for Alzheimer disease in a wild-type mouse model. JAMA 2009, 302:1796-1802.
17. Lambracht-Washington D., Qu B.X., Fu M., Anderson L.D., Stuve O., Eagar T.N., Rosenberg R.N. DNA immunization against amyloid beta 42 has high potential as safe therapy for Alzheimer's disease as it diminishes antigen specific Th1 and Th17 cell proliferation. Cell. Mol. Neurobiol. 2011, 31:867-874.
18. Lambracht-Washington D., Qu B.X., Fu M., Stüve O., Eagar T.N., Rosenberg R.N. A regulatory immune response after DNA vaccination against amyloid beta 42 (published abstract, AAIC 2012. Alzheimers Dement. 2012, 8(Suppl. 4). (P201/P1-272).
19. Mangialasche F., Solomon A., Winblad B., Mecocci P., Kivipelto M. Alzheimer's disease: clinical trials and drug development. Lancet Neurol. 2010, 9:702-707.
20. Ohshima Y., Yang L.P., Uchiyama T., Tanaka Y., Baum P., Sergerie M., Hermann P., Delespesse G. OX40 costimulation enhances interleukin-4 (IL-4) expression at priming and promotes the differentiation of naive human CD4(+) T cells into high IL-4-producing effectors. Blood 1998, 92:3338-3345.
21. Orgogozo J.M., Gilman S., Dartigues J.F., Laurent B., Puel M., Kirby L.C., Jouanny P., Dubois B., Eisner L., Flitman S., Michel B.F., Boada M., Frank A., Hock C. Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization. Neurology 2003, 61:46-54.
22. Pillemer B.B., Qi Z., Melgert B., Oriss T.B., Ray P., Ray A. STAT6 activation confers upon T helper cells resistance to suppression by regulatory T cells. J. Immunol. 2009, 83:155-163.
23. Qu B.-X., Xiang Q., Li L., Johnston S.A., Hynan L.S., Rosenberg R.N. Aβ42 gene vaccine prevents Aβ42 deposition in brain of double transgenic mice. J. Neurol. Sci. 2007, 260:204-213.
24. Qu B.X., Lambracht-Washington D., Fu M., Eagar T.N., Stüve O., Rosenberg R.N. Analysis of three plasmid systems for use in DNA Abeta 42 immunization as therapy for Alzheimer's disease. Vaccine 2010, 28:5280-5287.
25. Rosenblum M.D., Gratz I.K., Paw J.S., Lee K., Marshak-Rothstein A., Abbas A.K. Response to self antigen imprints regulatory memory in tissues. Nature 2011, 480:538-542.
26. Sanchez Rodriguez R., Pauli M.L., Neuhaus I.M., Yu S.S., Arron S.T., Harris H.W., Yang S.H., Anthony B.A., Sverdrup F.M., Krow-Lucal E., et al. Memory regulatory T cells reside in human skin. J. Clin. Invest. 2014, 24:1027-1036.
27. Schlapbach C., Gehad A., Yang C., Watanabe R., Guenova E., Teague J.E., Campbell L., Yawalkar N., Kupper T.S., Clark R.A. Human TH9 cells are skin-tropic and have autocrine and paracrine proinflammatory capacity. Sci. Transl. Med. 2014, 6(219):21.
28. Schreiber T.H., Wolf D., Tsai M.S., Chirinos J., Deyev V.V., Gonzalez L., Malek T.R., Levy R.B., Podack E.R. Therapeutic Treg expansion in mice by TNFRSF25 prevents allergic lung inflammation. J. Clin. Invest. 2010, 120:3629-3640.
29. Schreiber T.H., Wolf D., Bodero M., Gonzalez L., Podack E.R. T cell costimulation by TNFR superfamily (TNFRSF)4 and TNFRSF25 in the context of vaccination. J. Immunol. 2012, 189:3311-3318.
30. Skapenko A., Kalden J.R., Lipsky P.E., Schulze-Koops H. The IL-4 receptor alpha-chain-binding cytokines, IL-4 and IL-13, induce forkhead box P3-expressing CD25+CD4+ regulatory T cells from CD25-CD4+ precursors. J. Immunol. 2005, 175:6107-6116.
31. Weiss R., Scheiblhofer S., Freund J., Ferreira F., Livey I., Thalhamer J. Gene gun bombardment with gold particles displays a particular Th2-promoting signal that over-rules the Th1-inducing effect of immunostimulatory CpG motifs in DNA vaccines. Vaccine 2002, 20:3148-3154.
32. Wolf D., Schreiber T.H., Tryphonopoulos P., Li S., Tzakis A.G., Ruiz P., Podack E.R. Tregs expanded in vivo by TNFRSF25 agonists promote cardiac allograft survival. Transplantation 2012, 94:569-674.
33. Yonkers N.L., Sieg S., Rodriguez B., Anthony D.D. Reduced naive CD4 T cell numbers and impaired induction of CD27 in response to T cell receptor stimulation reflect a state of immune activation in chronic hepatitis C virus infection. J. Infect. Dis. 2011, 203:635-645.